Federico J Mensa Selected Research

deleobuvir

8/2016	Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.
1/2016	HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.
2/2015	Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study.
2/2015	Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.
1/2015	ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
8/2013	Faldaprevir and deleobuvir for HCV genotype 1 infection.
1/2013	Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Federico J Mensa Research Topics

Disease

32	Infections 01/2021 - 01/2013
20	Fibrosis (Cirrhosis) 01/2020 - 02/2015
14	Chronic Hepatitis C 01/2019 - 08/2013
5	Liver Diseases (Liver Disease) 10/2019 - 10/2017
3	Virus Diseases (Viral Diseases) 01/2021 - 02/2015
2	Chronic Renal Insufficiency 10/2019 - 10/2017
1	Reinfection 01/2019
1	Persistent Infection 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Flushing 01/2019
1	Nausea 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2015
1	Anemia 01/2015
1	Exanthema (Rash) 01/2013
1	Asthenia 01/2013
1	Pruritus (Itching) 01/2013

Drug/Important Bio-Agent (IBA)

24	glecaprevir and pibrentasvirIBA 01/2020 - 01/2017
15	Ribavirin (Virazole)FDA LinkGeneric 10/2019 - 01/2013
14	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2013
13	InterferonsIBA 01/2019 - 01/2013
12	glecaprevirIBA 10/2019 - 10/2016
11	pibrentasvirIBA 10/2019 - 10/2016
7	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 08/2013
7	deleobuvirIBA 08/2016 - 01/2013
7	faldaprevirIBA 08/2016 - 01/2013
6	SofosbuvirIBA 01/2019 - 10/2017
5	Pharmaceutical PreparationsIBA 01/2021 - 10/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2019
2	NucleosidesIBA 08/2016 - 01/2015
1	P-300IBA 08/2019
1	AcidsIBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	Reducing AgentsIBA 01/2019
1	daclatasvirIBA 01/2018
1	Proton Pump InhibitorsIBA 12/2017
1	trichostatin A (A 300)IBA 01/2017
1	Inosine TriphosphataseIBA 01/2015

Therapy/Procedure

8	Therapeutics 01/2019 - 08/2013
1	Opiate Substitution Treatment 01/2019
1	Retreatment 01/2019
1	Polypharmacy 01/2019
1	Duration of Therapy 01/2018